Remove Drug Pricing Remove Immunization Remove Vaccines
article thumbnail

STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more

STAT

The trade group, however, insisted the FDA “acted to benefit special interests, raise drug prices and deprive much of the public of access to a needed medicine.” A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S. ” A U.S.

article thumbnail

Drug Prices Are High Thanks to Research That Americans Pay For

NY Times

The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts

pharmaphorum

Regulatory pressures, lengthy drug development times, and the fact that drug prices have become politicised have raised risks and cut revenue projections, leading to the biotech sector falling out of fashion. Moreover, the range of companies benefiting from investor interest has not been limited to those developing a vaccine.

Vaccines 122
article thumbnail

JPM2023: Breakthroughs await, but so do roadblocks

pharmaphorum

These therapies have incredible potential to fight cancer and other diseases using the patient’s own immune system. Some will simply raise drug prices to get more money out of new drugs while they can; others are planning to phase in new indications in order to “reset the clock” as many times as they can.

article thumbnail

CMS Publishes Grab Bag of Proposed Changes to the Medicaid Drug Rebate Program

FDA Law Blog: Biosimilars

Absent from the statute is any requirement to report information on manufacturer costs and price setting. Nevertheless, riding on the wave of drug price transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drug price transparency reporting.

article thumbnail

Another U.S. biotech based on Chinese science 

STAT

have on vaccines in the U.S.? ’s vaccine views could shape policy President-elect Trump’s decision to entrust noted vaccine skeptic Robert F. One of particular import: What impact will his relationship with Robert F. Kennedy Jr. We have a look at that question today, discuss another U.S. How RFK Jr.’s

Vaccines 263
article thumbnail

January 2025 Newsletter

Safe Biologics

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?